Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorNavarro Mendivil, Alejandro
dc.contributor.authorCallejo Perez, Ana
dc.contributor.authorIranzo Gómez, Patricia
dc.contributor.authorCedres Perez, Susana
dc.contributor.authorMartínez Marti, Alexandre
dc.contributor.authorPardo Aranda, Nuria
dc.contributor.authorJiménez Flores, José Antonio
dc.contributor.authorSansano Valero, Irene
dc.contributor.authorMancuso, Francesco Mattia
dc.contributor.authorNuciforo, Paolo Giovanni
dc.contributor.authorVivancos Prellezo, Ana
dc.contributor.authorFelip Font, Enriqueta
dc.contributor.authorAmat, Ramon
dc.contributor.authorSaoudi Gonzalez, Nadia
dc.contributor.authorCarbonell, Caterina
dc.contributor.authorFrigola Rissech, Joan
dc.date.accessioned2021-12-01T13:17:30Z
dc.date.available2021-12-01T13:17:30Z
dc.date.issued2021-04
dc.identifier.citationFrigola J, Navarro A, Carbonell C, Callejo A, Iranzo P, Cedrés S, et al. Molecular profiling of long‐term responders to immune checkpoint inhibitors in advanced non‐small cell lung cancer. Mol Oncol. 2021 Apr;15(4):887–900.
dc.identifier.issn1574-7891
dc.identifier.urihttps://hdl.handle.net/11351/6634
dc.descriptionCàrrega d'alteracions cromosòmiques; Inhibidors del punt de control immunitari; Càrrega mutacional del tumor
dc.description.sponsorshipInstituto Carlos III-ISCIII. Grant Number: FIS PI17/00938. Fundacion Cientifica Asociación Española Contra el Cancer. Grant Number: GCB14142170. Catalan Government/AGAUR. Grant Number: 2017 – SGR – 1738
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesMolecular Oncology;15(4)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Tractament
dc.subjectMedicaments antineoplàstics - Ús terapèutic
dc.subjectPulmons - Càncer - Prognosi
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.meshProgression-Free Survival
dc.subject.meshAntineoplastic Agents
dc.subject.mesh/therapeutic use
dc.titleMolecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/1878-0261.12891
dc.subject.decscarcinoma de pulmón de células no pequeñas
dc.subject.decssupervivencia libre de progresión
dc.subject.decsantineoplásicos
dc.subject.decs/uso terapéutico
dc.relation.publishversionhttps://doi.org/10.1002/1878-0261.12891
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Frigola J, Carbonell C, Amat R] Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Navarro A, Callejo A, Iranzo P, Cedrés S, Martinez-Marti A, Pardo N, Saoudi-Gonzalez N] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Jimenez J, Nuciforo P] Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Sansano I] Unitat de Patologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Mancuso FM, Vivancos A] Cancer Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Felip E] Thoracic Cancers Translational Genomics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid33342055
dc.identifier.wos000605076800001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/PI17%2F00938
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple